Rivermark Medical, a medical device company developing innovative treatments for benign prostatic hyperplasia (BPH), today announced the completion of enrollment in its RAPID III pivotal clinical ...
The Biggest Misconception About Benign Prostatic Hyperplasia! Treatment Is Not Determined by Size AloneThere is a major misconception held by many who are diagnosed with benign prostatic hyperplasia ...
ProVerum Limited is a company that has made significant strides with its development of the ProVee System, a minimally invasive solution specifically designed for treating benign prostatic hyperplasia ...
DELRAY BEACH, Fla., Feb. 17, 2025 /PRNewswire/ -- The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, ...
I’m waking up more often at night to use the bathroom,” or “Even with medication, my urine flow is weak.” If you’ve noticed ...
A postmarketing study showed that the Optilume BPH system improved the flow of urine while leaving sexual function unchanged in men with benign prostatic hyperplasia (BPH), researchers reported at the ...
Midland Health and West Texas Urology announced that it is the only healthcare facility in the Midland/Odessa area to offer Aquablation therapy for the treatment of lower urinary tract symptoms ...
BPH prostate treatment market is evolving toward a more patient-focused, technology-driven ecosystem. As innovation in both pharmaceuticals and minimally invasive procedures accelerates, companies ...
The ultrasound-guided, heat-free procedure uses a waterjet to remove excess prostate tissue that can obstruct urine flow.
For patients with benign prostatic hyperplasia (BPH), treatment with α-blockers (ABs) was linked to worse cardiovascular outcomes compared with treatment 5-α reductase inhibitors (5-ARIs). These ...
The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...